Simulation of survival data
Right-censored survival data (status, follow-up and right censoring) has been simulated using survsim R package [Morina and Navarro, 2014] . In order to simulate censored survival data, two survival distributions are required, one for the uncensored survival times that would be observed if the follow-up had been sufficiently long to reach the event and another representing the censoring mechanism. Here we used the Weibull distribution for both of them as in default setting of the function simple.surv.sim. We include in the simulation model three covariates following a Bernoulli distribution each with probability of success respectively p = 0.6, p = 0.4 and p = 0.15 (option x = list("bern", 0.6) of the function simple.surv.sim) to simulate a multi-group design each representative of a different omic combination and characterised by different survivals. The value of p determines the sample size of the groups (p = 0.6 will guarantee that, given the requested total sample size n, approximately 60% of the data will be assigned to one group and 40% to the other) and the values were set to be as close as possible to real scenarios, were expression and methylations alterations are usually shared by larger number of patients with respect to mutation or CNV events. We used n = 300 patients for both the whole pathway and module test. The function simple.surv.sim allows setting the value of the coefficients associated to the covariate that defines the groups. The higher the , the higher the impact of the covariate on the model and the stronger the difference between the two classes. Here, we set = 0.8. 5%  3%  8%  3%  4%  2%  100%  5%  6%  7%  4%  7%  4%  4%  7%  3%  6%  1%  2%  99%  8%  4%  3%  6%  3%  2%  4%  5%  7%  10%  1%  5%  2% −log10(pvalue) 2%  7%  4%  6%  6%  8%  94%  9%  4%  6%  4%  7%  5%  4%  4%  8%  3%  6%  2%  99%  7%  3%  4%  5%  6%  7%  10%  7%  7%  10%  3%  3%  4% −log10(pvalue) 11%  6%  4%  4%  4%  100%  100%  6%  7%  6%  8%  8%  7%  9%  10%  3%  1%  9%  3%  3%  5%  6%  2%  5%  3%  100%  10%  5%  7%  5%  5%  4%  6% −log10(pvalue) 7%  11%  5%  6%  10%  100%  100%  7%  12%  9%  7%  7%  11%  11%  7%  3%  4%  7%  6%  5%  2%  3%  5%  5%  2%  100%  11%  5%  2%  2%  6%  4%  5% −log10(pvalue) 
Know Literature Genes about Ovarian Cancer
Literature curated knowledgebase of marker genes in Ovarian Cancer. We manually selected the state-ofthe-art knwoledge on ovarian cancer omics analysis. Table S1 is enriched with MOSClip results: "PenKept" columns indicate with '+' if the gene was selected from the penalized analysis. In "MOSClip" column '+' means that the gene was detected by MOSClip module analysis. Pathway column indicates that the gene is not directly detected in a module but is close to a significant module in the pathway. 
Pathway results

Whole pathway summary
We run MOSClip on all the pathways with more than 10 nodes. Table S2 summarized those with an overall pvalue <= 0,05. In the last column, we reported the number of times the pathway overall pvalue remains significant (overall pvalue <= 0.05) in 100 courts of patients obtained by randomly removing the 1% (n=3) of the patients from the whole batch of patients. We reported 33 pathways, i.e. those with resampling success of at least 80. 
Results summarized by omics: Super Exact Test
To better understand the overall meaning of the pathways associated to patients' survival, we run the superexact test. In table S3 we report for each omic intersection the pathways that share the activated omics. Table S4 contains the macro categories (macro-pathway, i.e the ancestor in the Reactome hierarchy) and the number of pathways that belong to each macro category that have been found significant across di erent omic intersections. 
Module Results
Module Summary
For module analysis, we run MOSClip on all the pathways with less than 101 and with more than 19 nodes (20 <= nodes <= 100). Table S5 summarized the modules with an overall pvalue <= 0,05. In the last column (rCounts), we reported the number of times the module overall pvalue remains significant (overall pvalue <= 0.05) in 100 courts of patients obtained by randomly removing the 1% (n=3) of the patients from the whole batch of patients. We reported those with resampling success of at least 80. 
Results summarized by omics: Super Exact Test
To better understand the overall meaning of the modules associated to patients survival, we run the superexact test (SuperExactTest R package). In table S6 we report for each omic intersection the modules that share the activated omics. The modules are reported in the notation "pathway name"."module number". composed by the gene of tested pathways with measured expression; genes of the tested pathways with methylation levels deteted; module mutation profiles, module based cnv profiles. Mutation and CNVs are all the profiles tested by the COX model during MOSclip module test. Given the heterogeneity of the measurements, the matrix was scale using scale R function with default parameters. We checked our signature against 1000 random signatures. In Figure S7 we show our signature lays far from the distribution of 1000 random signatures. Similarly, we checked the power of our signature comparing it with "known" signatures, i.e. the gene signatures available at the Broad Institute's MSigDB site [Subramanian et al., 2005 , Liberzon et al., 2015 . We downloaded the oncogenic signatures (c6: oncogenic signatures gene sets). The test is meant to demonstrate that a multiomic signature outperform the broadly used gene signatures. As shown in Figure S8 our signature (solid red line) outperform the 189 known signatures from MSigDB. 
